Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 2/2005

01-04-2005 | Editorial

Letter from the editor

Author: Paul Davis

Published in: Clinical Rheumatology | Issue 2/2005

Login to get access

Excerpt

The year 2005 will be an important and hopefully defining year for Clinical Rheumatology. First, we say a fond farewell to Dr. Jan Dequeker as its Editor in Chief, Jan has nurtured the journal since its inception and has seen it grow under his leadership. One of his most important achievements is having the journal adopted by the International League of Associations for Rheumatology (ILAR). The continued development of this association will, over time, allow the journal to develop as a true voice for worldwide rheumatology. Those of us involved in Clinical Rheumatology and its progress extend our grateful thanks to Jan and his dedicated staff and wish him all the best for the future, knowing that he will always be in the wings to guide us when needed. …
Metadata
Title
Letter from the editor
Author
Paul Davis
Publication date
01-04-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-1094-9

Other articles of this Issue 2/2005

Clinical Rheumatology 2/2005 Go to the issue

Letter

Reply to letter by Franco et al.

Case Report

Variable atrioventricular block in systemic lupus erythematosus

Original Article

The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity

Case Report

Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C

Case Report

Microscopic polyangiitis sparing the kidneys in a long-term survivor after allogenic bone marrow transplantation and graft-versus-host disease

Case Report

Acute respiratory distress syndrome due to systemic lupus erythematosus with hemophagocytic syndrome: an autopsy report
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits